Literature DB >> 10466842

Testing 40 predictions from the transtheoretical model.

W F Velicer1, G J Norman, J L Fava, J O Prochaska.   

Abstract

Sensitive measurement of behavior change requires dependent measures that are sensitive to the whole spectrum of change, not just a single aspect of change. Traditional outcome variables such as point prevalence for smoking cessation focus on a single discrete event and ignore all other progress. Alternatively, the criterion measurement model (CMM) is an approach that posits a three-construct outcome model (habit strength, positive evaluation strength, and negative evaluation strength), where different constructs are sensitive to change for different aspects of the temporal domain. In this article, a series of 40 differential a priori predictions were tested using a large representative sample of smokers. The focus was on the prediction of specific effect sizes rather than statistical significance. A series of comparisons involving stage transitions was examined using five variables representing the three CMM constructs. The predictions involved movement from one of three initial stages (precontemplation, contemplation, and preparation) to stage membership 12 months later. Thirty-six of the 40 predictions were confirmed, indicating that the outcome model has strong construct validity and accurately reflects movement between the stages of change.

Entities:  

Mesh:

Year:  1999        PMID: 10466842     DOI: 10.1016/s0306-4603(98)00100-2

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  27 in total

1.  Cluster randomised controlled trial of expert system based on the transtheoretical ("stages of change") model for smoking prevention and cessation in schools.

Authors:  P Aveyard; K K Cheng; J Almond; E Sherratt; R Lancashire; T Lawrence; C Griffin; O Evans
Journal:  BMJ       Date:  1999-10-09

2.  Does user satisfaction relate to adoption behavior?: an exploratory analysis using CPRS implementation.

Authors:  C R Weir; R Crockett; S Gohlinghorst; C McCarthy
Journal:  Proc AMIA Symp       Date:  2000

Review 3.  Readiness for return to work following injury or illness: conceptualizing the interpersonal impact of health care, workplace, and insurance factors.

Authors:  Renée-Louise Franche; Niklas Krause
Journal:  J Occup Rehabil       Date:  2002-12

4.  Extending Theory-Based Quantitative Predictions to New Health Behaviors.

Authors:  Leslie Ann D Brick; Wayne F Velicer; Colleen A Redding; Joseph S Rossi; James O Prochaska
Journal:  Int J Behav Med       Date:  2016-04

5.  Predictors of smoking reduction outcomes in a sample of 287 patients with schizophrenia spectrum disorders.

Authors:  Bo-Jian Wu; Tsuo-Hung Lan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-27       Impact factor: 5.270

6.  Do daily interactive voice response reports of smoking behavior correspond with retrospective reports?

Authors:  Benjamin A Toll; Ned L Cooney; Sherry A McKee; Stephanie S O'Malley
Journal:  Psychol Addict Behav       Date:  2005-09

7.  Transtheoretical model of health behavior change applied to voice therapy.

Authors:  Eva van Leer; Edie R Hapner; Nadine P Connor
Journal:  J Voice       Date:  2007-12-21       Impact factor: 2.009

8.  Predictors of relapse among smokers: transtheoretical effort variables, demographics, and smoking severity.

Authors:  N S Gökbayrak; A L Paiva; B J Blissmer; J O Prochaska
Journal:  Addict Behav       Date:  2014-11-26       Impact factor: 3.913

9.  Validity of stage assessment in the adoption and maintenance of physical activity and fruit and vegetable consumption.

Authors:  Sonia Lippke; Jochen P Ziegelmann; Ralf Schwarzer; Wayne F Velicer
Journal:  Health Psychol       Date:  2009-03       Impact factor: 4.267

10.  Correlates of the stages of change for physical activity in a population survey.

Authors:  Carol Ewing Garber; Jenifer E Allsworth; Bess H Marcus; Jana Hesser; Kate L Lapane
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.